Cited by 193Probiotics and Fermented FoodsInflammatory Bowel DiseaseGut microbiota and health

The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.

Clinical effects and gut microbiota changes of using probiotics, prebiotics or synbiotics in inflammatory bowel disease: a systematic review and meta-analysis

Zhang, Xiao-Feng, Guan, Xiao-Xian, Tang, Yu-Jun, Sun, Jin-Feng, Wang, Xiao-Kai, Wang, Wei-Dong, Fan, Jian-Ming·2021·European Journal of Nutrition

DOI 10.1007/s00394-021-02503-5

Open this paper in CoChat — free account

Abstract

Purpose Probiotics have been reported to be beneficial for inflammatory bowel disease (IBD), but the types, number of strains, dosage, and intervention time of probiotics used remain controversial. Furthermore, the changes of gut microbiota in IBD's patients are also intriguing. Thus, this meta-analysis was to explore the clinical effects and gut microbiota changes of using probiotics, prebiotics and synbiotics in IBD.Methods The search was performed in PubMed, Web of Science and the Cochrane library from inception to April 2020. Qualified randomized controlled trials were included. IBD's remission rate, disease activity index and recurrence rate were extracted and analyzed. Changes in the gut microbiota of patients with IBD are comprehensively described.Results Thirty-eight articles were included. Probiotics, prebiotics and synbiotics can induce/maintain IBD's remission and reduce ulcerative colitis (UC) disease activity index (RR = 1.13, 95% CI 1.02, 1.26, P < 0.05; SMD = 1.00, 95% CI 0.27, 1.73, P < 0.05). In subgroup analyses of IBD remission rate and UC disease activity index, we obtained some statistically significant results in some subgroup (P < 0.05). To some extent, probiotic supplements can increase the number of beneficial bacteria (especially Bifidobacteria) in the intestinal tract of patients with IBD.Conclusions Our results support the treatment of IBD (especially UC) with pro/pre/synbiotics, and synbiotics are more effective. Probiotic supplements that are based on Lactobacillus and Bifidobacterium or more than one strain are more likely to be beneficial for IBD remission. The dose of 10 10-10 12 CFU/day may be a reference range for using probiotics to relieve IBD.

Integrity signals

Registry

Crossref · 10.1007/s00394-021-02503-5

Cites

84 of 84 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
The “Golden Age” of Probiotics: A Systematic Review and Meta-Analysis of Randomized and Observational Studies in Preterm Infants
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,586
Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics
Gibson, G. R., Hutkins, R., Sanders, M. E., Prescott, S. L., Reimer, R. A., Salminen, S. J., Scott, K., Stanton, C., Swanson, K. S., Cani, P. D., et al. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.75 · Cited by 5,634
The global burden of IBD: from 2015 to 2025
Kaplan, G. G. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.150 · Cited by 2,639
The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Alatab, S., Sepanlou, S. G., Ikuta, K., Vahedi, H., Bisignano, C., Safiri, S., Sadeghi, A., Nixon, M. R., Abdoli, A., Abolhassani, H., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30333-4 · Cited by 2,313
Mechanisms of action of probiotics
Plaza-Diaz, J., Ruiz-Ojeda, F. J., Gil-Campos, M., & Gil, A. (2019) · Advances in Nutrition · doi:10.1093/advances/nmy063 · Cited by 1,423
Probiotics, prebiotics and synbiotics- a review
Pandey, K. R., Naik, S. R., & Vakil, B. V. (2015) · Journal of Food Science and Technology · doi:10.1007/s13197-015-1921-1 · Cited by 1,350
Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine
Kruis, W., Frič, P., Pokrotnieks, J., Lukáš, M., Fixa, B., Kaščák, M., Kamm, M. A., Weismueller, J., Beglinger, C., Stolte, M., et al. (2004) · Gut · doi:10.1136/gut.2003.037747 · Cited by 1,285
Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial
Rembacken, B., Snelling, A. M., Hawkey, P. M., Chalmers, D. M., & Axon, A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)06343-0 · Cited by 1,100

Flagged first, then by citations

Show all 84 references

Sorted by citations

Items 101–193 of 193

Intestinal microecology dysbiosis in inflammatory bowel disease: Pathogenesis and therapeutic strategies
Yin, Y., Feng, W., Chen, X., Chen, J., Wang, G., Xia, L., & Wu, K. (2024) · The Innovation Medicine · doi:10.59717/j.xinn-med.2024.100092 · Cited by 11
Prebiotics and Probiotics Supplementation in Pigs as a Model for Human Gut Health and Disease
Rossi, R., & Mainardi, E. (2025) · Biomolecules · doi:10.3390/biom15050665 · Cited by 17
The effects of synbiotics surpass prebiotics in improving inflammatory biomarkers in children and adults: A systematic review, meta-analysis, and meta-evidence of data from 5207 participants in 90 randomized controlled trials
Zhang, Y., Hong, J., Zhang, Y., Gao, Y., & Liang, L. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107832 · Cited by 15
Non-prescription Therapeutics
Weingarden, A. R., & Ko, C. W. (2023) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002578 · Cited by 11
Probiotics and inflammatory bowel disease: An umbrella meta-analysis of relapse, recurrence, and remission outcomes
Liu, W., Zhang, S., Dong, C., Lv, X., Zheng, X., Zhao, W., Jamali, M., Abedi, R., & Saedisomeolia, A. (2025) · Nutrition & Metabolism · doi:10.1186/s12986-025-01002-2 · Cited by 9
Integrative Multiomics Profiling Unveils the Protective Function of Ulinastatin against Dextran Sulfate Sodium-Induced Colitis
Yu, T., Yan, J., Wang, R., Zhang, L., Hu, X., Xu, J., Li, F., & Sun, Q. (2024) · Antioxidants · doi:10.3390/antiox13020214 · Cited by 9
Probiotics for Inflammatory Bowel Disease; A Deep Dive into their Impact on Disease Course and Associated Health Risks
Nori, W., Al-kaabi, M. M., Akram, N. N., Kassim, M. A. K., & Pantazi, A. C. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673314861240429072352 · Cited by 10
Recognizing the biological barriers and pathophysiological characteristics of the gastrointestinal tract for the design and application of nanotherapeutics
Li, S., Wu, T., Wu, J., Chen, W., & Zhang, D. (2024) · Drug Delivery · doi:10.1080/10717544.2024.2415580 · Cited by 9
Shared and Distinct Gut Microbial Profiles in Saudi Women with Metabolically Healthy and Unhealthy Obesity
Aljuraiban, G. S., Alfhili, M. A., Aldhwayan, M., Aljazairy, E. A., & Al-Musharaf, S. (2023) · Microorganisms · doi:10.3390/microorganisms11061430 · Cited by 7
How to increase dietary polyphenol bioavailability: Understanding the roles of modulating factors, lifestyle and gut microbiota
Dzah, C. S. (2025) · Food and Humanity · doi:10.1016/j.foohum.2025.100602 · Cited by 10
Bidirectional Interplay Between IBD Therapies and the Gut Microbiota: A Pharmacomicrobiomic Approach to Personalized Treatment
Lazarević, S., Đanić, M., & Pavlović, N. (2025) · BioDrugs · doi:10.1007/s40259-025-00739-9 · Cited by 8
Interactions of bile acids and gut microbiota modulate neurological health: a comprehensive review on mechanisms and therapeutic potential of dietary phytochemicals
Wang, J., Zhang, Y., Wu, Q., Zhong, Y., Xu, Z., & Yang, J. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1757551 · Cited by 10
Gut microbiota in inflammatory bowel disease: a target for therapy not to be missed
LARUSSA, T., Abenavoli, L., FABIANO, G., MANCUSO, M. A., POLIMENI, N., DUMITRASCU, D. L., & Luzza, F. (2022) · Minerva Gastroenterology · doi:10.23736/s2724-5985.21.02907-7 · Cited by 8
Inflammatory Bowel Diseases and the Efficacy of Probiotics as Functional Foods
Vitetta, L., Oldfield, D., & Sali, A. (2024) · Frontiers in Bioscience-Elite · doi:10.31083/j.fbe1602013 · Cited by 9
Effects of non-pharmacological interventions on gut microbiota and intestinal permeability in older adults: A systematic review
Hisham, H. I. H., Lim, S. M., Neoh, C. F., Majeed, A. B. A., Shahar, S., & Ramasamy, K. (2024) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2024.105640 · Cited by 9
Impact of Ligilactobacillus salivarius Li01 on benzo[a]pyrene-induced colitis, based on host-microbiome interactions in Mongolian gerbils
Huang, Y., Yang, C., Fu, B., Guo, H., Chen, Y., & Xu, D. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1494525 · Cited by 8
Preliminary Comparison of Endoscopic Brush and Net Catheters as the Sampling Tool to Analyze the Intestinal Mucus in the Rectum with Ulcerative Colitis Patients
Nakamura, M., Maeda, K., Yamamoto, K., Yamamura, T., Sawada, T., Ishikawa, E., Kakushima, N., Furukawa, K., Iida, T., Mizutani, Y., et al. (2022) · Digestion · doi:10.1159/000521929 · Cited by 8
Lactobacillus fermentum CKCC1858 and Lactobacillus plantarum CKCC1312 ameliorate the symptoms of ulcerative colitis in mouse model induced by dextran sulfate sodium
Li, A., Zhang, L., Chen, L., Wang, J., Liu, A., Luo, P., Zhan, M., Zhou, X., Chen, L., & Zhang, J. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105995 · Cited by 9
Characterization of growth and metabolomic profiles of Lacticaseibacillus paracasei ProSci-92 as a potential probiotic culture in extended milk fermentation
Wu, T., Guo, S., Kwok, L., Wang, J., & Zhang, H. (2025) · Journal of Dairy Science · doi:10.3168/jds.2024-26189 · Cited by 7
Protective Role of Limosilactobacillus fermentum Lf2 and Its Exopolysaccharides (EPS) in a TNBS-Induced Chronic Colitis Mouse Model
Ale, E. C., Irazoqui, J. M., Ale, A., Peralta, G. H., Puntillo, M. A., Burns, P., Olivar, G. C., Cazenave, J., Bergamini, C. V., Amadío, A., et al. (2024) · Fermentation · doi:10.3390/fermentation10020077 · Cited by 7
The INHABIT (synergIstic effect of aNtHocyAnin and proBIoTics in) Inflammatory Bowel Disease trial: a study protocol for a double-blind, randomised, controlled, multi-arm trial
Cosier, D., Lambert, K., Batterham, M., Sanderson-Smith, M., Mansfield, K., & Charlton, K. (2024) · Journal of Nutritional Science · doi:10.1017/jns.2023.113 · Cited by 6
Bottom‐Up Design of Prebiotics and Probiotics: An Intestinal Microbiota‐Centered Approach to Chronic and Functional Constipation Management
He, P., Chen, S., Lyu, C., An, R., & Wang, D. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70140 · Cited by 6
Biological Response of Treatment with Saffron Petal Extract on Cytokine-Induced Oxidative Stress and Inflammation in the Caco-2/Human Leukemia Monocytic Co-Culture Model
Cecco, F. D., Franceschelli, S., Panella, V., Maggi, M. A., Bisti, S., Bravo‐Nuevo, A., D’Ardes, D., Cipollone, F., & Speranza, L. (2024) · Antioxidants · doi:10.3390/antiox13101257 · Cited by 7
A Systemic Perspective of the Link Between Microbiota and Cardiac Health: A Literature Review
Grigore, I., Ciobotaru, O. R., Hînganu, D., Gurău, G., Tutunaru, D., & Hînganu, M. V. (2025) · Life · doi:10.3390/life15081251 · Cited by 7
The Synergistic Role of Sargassum horneri Fucoidan and Lactobacillus plantarum: Microbiome and Gut Barrier Restoration in Zebrafish Colitis
Liyanage, N. M., Nagahawatta, D. P., Jayawardhana, H. H. A. C. K., Je, J.-G., Yiqiao, L., Yang, F., Kim, Y.-S., Ko, K. Y., & Jeon, Y. (2025) · Marine Drugs · doi:10.3390/md23100372 · Cited by 5
Lactiplantibacillus plantarum L47 and inulin affect colon and liver inflammation in piglets challenged by enterotoxigenic Escherichia coli through regulating gut microbiota
Miao, J., Cui, L., Zeng, H., Hou, M., Wang, J., & Hang, S. (2024) · Frontiers in Veterinary Science · doi:10.3389/fvets.2024.1496893 · Cited by 5
Anti‐Inflammatory Peptides as Promising Therapeutics Agent Against Inflammatory Bowel Diseases: A Systematic Review
Ghazvini, K., Taghiabadi, Z., Karimi, M. A., Bafghi, M. H., Paryan, M., & Amirfakhrian, R. (2025) · JGH Open · doi:10.1002/jgh3.70212 · Cited by 7
The Role of Gut Microbiome in the Pathogenesis and the Treatment of Inflammatory Bowel Diseases
Vidal-Gallardo, A., Benítez, J. E. M., Rios, L. F., Meza, L. F. O., Pérez, R. A. M., Romero, E. M., Vargas-Beltran, A. M., Hernandez, J. L. B., Banegas, D., Perez, B., et al. (2024) · Cureus · doi:10.7759/cureus.54569 · Cited by 5
Effect of intestinal microbiome, antibiotics, and probiotics in the prevention and management of ulcerative colitis
Kushkevych, I. V., & Jampílek, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823733-5.00016-7 · Cited by 5
Effects of Commercial Probiotics on Colonic Sensitivity after Acute Mucosal Irritation
López‐Gómez, L., Antón, J., López‐Tofiño, Y., Pomana, B., Uranga, J. A., & Abalo, R. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19116485 · Cited by 5
From signals to systems: the epigenetic-microbiome-mitochondrial axis in IBD pathogenesis
Kazemifard, N., Shahrokh, S., Dimitrov, G., Totonchi, M., & Dimitrov, S. I. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2692755 · Cited by 4
The effects of probiotics in ulcerative colitis patients: a randomized controlled double blind clinical trial
Tamizifar, B., Feizi, A., khorasani, M. R., Kassaian, N., Zamanimoghadam, A., Arbabnia, S., & Adibi, P. (2023) · Functional Foods in Health and Disease · doi:10.31989/ffhd.v13i11.1098 · Cited by 4
Synergistic effect of partially hydrolyzed guar gum on Clostridium butyricum in a synbiotic combination for enhanced butyrate production during in-vitro fermentation
Matsumiya, Y., Kapoor, M. P., Yamaguchi, A., Abe, A., & Sato, N. (2024) · Functional Foods in Health and Disease · doi:10.31989/ffhd.v14i7.1385 · Cited by 4
Exploring the microbial basis of postbiotic and paraprobiotic therapy in ulcerative colitis
Pavithra, N., Devi, M., Nirenjen, S., Keerthana, B., Kumar, V., Yogalakshmi, R., Priyadharshni, M. G., & Harikrishnan, N. (2025) · Archives of Microbiology · doi:10.1007/s00203-025-04561-3 · Cited by 3
Qing-Chang-Hua-Shi granule ameliorates experimental colitis by modulating Lactobacillus gasseri-mediated ferroptosis metabolic pathway
Cheng, C., Zhu, L., Hu, J., Feng, W., Li, W., Au, R., Li, Y., Xu, F., Wu, Y., Cui, Y., et al. (2026) · Chinese Medicine · doi:10.1186/s13020-025-01317-5 · Cited by 3
Agarotriose Alleviates Colitis by Promoting Akkermansia muciniphila -Derived Spermidine Production to Suppress PI3K/AKT/NF-κB Signaling
Cai, Y., Sun, J., 陈思铭, Wang, D., Jing, Y., Jin, X., Li, Z., Li, C., & Ban, X. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c16297 · Cited by 3
Self-citation
The impact of knowledge and attitudes on physicians', nurses' and pharmacists' recommendation of probiotics: A systematic review
Fei, Y. Y., Steen, J. P., Tutt, E., Ng, J. Y., & Dobbins, M. (2023) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2023.102272 · Cited by 3
Synbiotic regulation of chronic intestinal inflammation by Sargassum horneri fucoidan and Lactobacillus plantarum
Liyanage, N. M., Nagahawatta, D. P., Yang, F., Kim, Y.-S., Kim, D., & Jeon, Y. (2025) · Journal of Functional Foods · doi:10.1016/j.jff.2025.106988 · Cited by 3
Maintenance of intestinal epithelial barrier integrity by a combination of probiotics, herbal extract, and vitamins
Cocetta, V., Giacomini, I., Tinazzi, M., Berretta, M., Quagliariello, V., Maurea, N., Ragazzi, E., Carnevali, I., & Montopoli, M. (2023) · Minerva Pediatrics · doi:10.23736/s2724-5276.23.07128-8 · Cited by 3
"EFFECT OF DIETARY PROBIOTICS ON INTESTINAL MICROBIOTA IN PATIENTS WITH CROHN’S DISEASE"
Pavel, F. M., Ţiţ, D. M., Bungău, A. F., Behl, T., Tarce, A. G., & BUNGAU, S. G. (2022) · Archives of the Balkan Medical Union · doi:10.31688/abmu.2022.57.1.07 · Cited by 3
İnflamatuvar Bağırsak Hastalığı Tanısı Alan Yetişkin Bireylerde Mikrobiyota Farkındalığı ve Akdeniz Diyetine Uyumun Değerlendirilmesi
Kumral, S. N., Katırcıoğlu, B., Tekin, N., ÖZTÜRK, S. N., & Ayyıldız, F. (2023) · Black Sea Journal of Health Science · doi:10.19127/bshealthscience.1362512 · Cited by 2
Exploring the efficacy of a novel prebiotic-like growth promoter on broiler chicken production performance
Haq, Z., Rastogi, A., Sharma, R. K., Raghuwanshi, P., Singh, M. P., Khan, A. A., & Ahmad, S. M. (2023) · Veterinary and Animal Science · doi:10.1016/j.vas.2023.100331 · Cited by 3
Kefir and Its By-Products Supplementation Reduces Inflammation and Oxidative Stress, Improves Intestinal Barrier Integrity, and Modulates the Gut Microbiota in Animal Models of Inflammatory Bowel Disease: A Systematic Review
Neves, M. A. S., de Paulo, R. S., Bressan, J., Pereira, S. S., Kravchychyn, A. C. P., & Hermsdorff, H. H. M. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-10948-5 · Cited by 3
Prescribed probiotic usage to prevent Clostridioides difficile infection among older patients receiving antibiotics: A retrospective cohort study
Mori, N., Katsumata, T., & Takahashi, T. (2023) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2023.05.001 · Cited by 2
The role of functional foods in the management of gastrointestinal diseases: a comprehensive review of recent evidence
Tabak, G., & Çiftçi, S. (2024) · Nutrire · doi:10.1186/s41110-024-00280-9 · Cited by 2
Association between prebiotic, probiotic consumption and hyperuricemia in U.S. adults: a cross-sectional study from NHANES 2011–2018
Wang, Y., Li, S., Li, X., Wang, M., Huang, B., Feng, K.-L., & Cui, J. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1492708 · Cited by 2
Immunostimulatory Role of Prebiotics and Probiotics
Mohanty, T., Gurjar, B. P., Yangala, S. B., & Nagarajan, U. (2022) · doi:10.1002/9781394167227.ch7 · Cited by 2
The Role of Bacterial Toxins and Environmental Factors in the Development of Food Allergies
Unar, A., Qureshi, M., Afridi, H. I., & Wassan, S. (2024) · Allergies · doi:10.3390/allergies4040014 · Cited by 1
The Microbiome and Inflammatory Bowel Diseases.
Dalal, S. (2025) · Surgical Clinics of North America · doi:10.1016/j.suc.2025.06.007 · Cited by 1
Therapeutic Interventions for Inflammatory Bowel Disease and Predictive Biomarkers of Therapeutic Response
Siddiqui, M. A., Agrawal, N., Gupta, S., Lanjhiyana, S. K., Jaiswal, M., & Gupta, V. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898814021126010005 · Cited by 1
Analysis of Tim-4 expression in ulcerative colitis and its association with inflammation-related immune infiltration
Liu, Y., Wang, Y., Wang, X., Zhu, L., Zhao, C., Zhu, J., & Wang, X. (2026) · Immunology Letters · doi:10.1016/j.imlet.2026.107173 · Cited by 1
Self-citation
Comparison of Viable and Heat‐Inactivated Lacticaseibacillus rhamnosus IDCC 3201: Anti‐Pathogenic, Anti‐Inflammatory, and Microbiota Modulating Effect
Kim, H., Lee, H., Bang, W. Y., Park, H., & Moon, J. S. (2026) · Food Science & Nutrition · doi:10.1002/fsn3.71780 · Cited by 1
Oral probiotic delivery-based therapeutic strategies for inflammatory bowel disease
Li, S., Deng, H., Fu, S., Li, J., Luo, X., Chen, Z., Wang, P., Feng, X., Chen, Y., Fu, C., et al. (2026) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2026.101187 · Cited by 2
Bifidobacterium and the gut–immune axis: Mechanistic insights and therapeutic potential
Ramesh, A., Subbarayan, R., Shrestha, R., Krishnamoorthy, L., & Radhakrishnan, A. (2026) · Microbiological Research · doi:10.1016/j.micres.2026.128686 · Cited by 1
RISK FACTORS AND PREVENTION OF COLONIC DISEASES: MODERN APPROACHES AND PERSPECTIVES (LITERATURE REVIEW)
Murzagulov, N. A., Telmanova, Z., Shishkin, I., Rustemova, K., & Igissinov, N. (2026) · Evrazijskij žurnal zdravoohraneniâ. · doi:10.54890/1694-8882-2026-1-157 · Cited by 1
Microbiome-Based Therapeutics: Emerging Trends in Health Biotechnology
Ullah, I., & Yasmin, M. (2024) · Premier journal of science. · doi:10.70389/pjs.100022 · Cited by 2
Protective and regenerative roles of novel probiotic strains in mitigating cyclophosphamide-induced genotoxicity and organ damage in mice
Hassan, E. E., Ibrahim, N. E., Menshawy, M. M., Darwish, A. M., Khattab, A.-E. N. A., & Farghaly, A. A. (2025) · Gene Reports · doi:10.1016/j.genrep.2025.102271 · Cited by 1
Acute pancreatitis gut dysbiosis persists at 1‐year follow‐up and is associated with clinical outcomes
Dike, C. R., Duan, Q., Ahmed, F., Denson, L. A., Haslam, D. B., Minar, P., Ollberding, N. J., Papachristou, G. I., Setchell, K. D. R., Thompson, T., et al. (2025) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/jpn3.70135 · Cited by 1
Unraveling the Converging Roles of ASC-Dependent Inflammasomes, Interleukin-1 Superfamily Members, Serum Amyloid A, and Non-Sterile Inflammation in Disease Pathology and Fibrosis in Inflammatory Bowel Disease and Primary Sclerosing Cholangitis
Losa, M., Schwarzfischer, M., Emmenegger, M., Spalinger, M. R., Rogler, G., & Scharl, M. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26168042 · Cited by 2
Probiotics in Inflammatory Bowel Diseases
Singh, B., Mal, G., Kalra, R. S., & Marotta, F. (2024) · Springer eBooks · doi:10.1007/978-3-031-65459-6_8 · Cited by 1
Research Progress of Relapse Factors in Inflammatory Bowel Disease
罗, 叶. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.127924
Efficiency of Treatment Targeted on Gut Microbiota in Inflammatory Bowel Diseases: Current Strategies and Perspectives
Lazăr, D. C., Moacă, E.-A., Cornianu, M., Tăban, S. M., Faur, A. C., & Goldiș, A. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.108664
The gut microbiome in health and disease: Inflammatory bowel diseases
El-Sahhar, S., & Varga‐Weisz, P. (2022) · Advances in ecological research/Advances in Ecological Research · doi:10.1016/bs.aecr.2022.09.005
Chronische Immunaktivierung
Straub, R. H. (2022) · Springer eBooks · doi:10.1007/978-3-662-65238-1_4
Chronic Immune System Activation
Straub, R. H. (2023) · Springer eBooks · doi:10.1007/978-3-662-66751-4_4
Hiroshima University Affiliated Hospital Probiotics Usage Guidelines
Hiyama, T., Kunihiro, M., Asayama, N., Urabe, Y., Okanobu, H., Onogawa, S., Kunihiro, K., Kuwai, T., Kodama, M., Sanomura, Y., et al. (2023) · Nihon Daicho Komonbyo Gakkai Zasshi · doi:10.3862/jcoloproctology.76.467
Bağırsak Mikrobiyotası ve Gastrointestinal Sistem Hastalıklarında Probiyotiklerin Mikrobiyotaya Etkisi
YILMAZ, K., & KARLI, K. (2023) · Kastamonu Üniversitesi Sağlık Bilimleri Fakültesi Dergisi · doi:10.59778/sbfdergisi.1314182 · Cited by 1
Gut Microbiota and Inflammatory Bowel Diseases
Jacob, A., & Mathew, J. (2023) · doi:10.1002/9781119904786.ch10
Anti-inflammatory peptides as promising therapeutics agent against inflammatory bowel diseases: A systematic reviewPreprint
Ghazvini, K., Amirfakhrian, R., & Taghiabadi, Z. (2023) · Research Square · doi:10.21203/rs.3.rs-3404245/v1
Probiotics as Curators of a Healthy Gut Microbiota
Mills, S., Murphy, A., Dinan, T. G., Cryan, J. F., Stanton, C., & Ross, R. P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99971-7.00006-0
A systematic assessment on the influence of probiotics on patients with Inflammatory Bowel Disorder
Upadhye, V. J., Ballal, S., Singh, S., & Rani, R. (2024) · Multidisciplinary Reviews · doi:10.31893/multirev.2023ss022
Intestinal flora and ulcerative colitis: A Mendelian Randomization studyPreprint
Qu, F., Cheng, M., Wang, H., Ji, J., Lei, Y., & Zhou, Z. (2024) · Research Square · doi:10.21203/rs.3.rs-4005538/v1
Comment on “Environmental factors and their impact on chronic pain development and maintenance.”
Parada, C. A., & Nunes, Y. C. (2024) · Physics of Life Reviews · doi:10.1016/j.plrev.2024.06.007
Die intestinale Mikrobiota bei chronisch-entzündlichen Darmerkrankungen
Misselwitz, B., & Haller, D. (2025) · Die Innere Medizin · doi:10.1007/s00108-024-01845-6
Lactiplantibacillus plantarum TXZ 2-35 protects mice against ulcerative colitis by inhibiting ferroptosis and regulating of intestinal microbiota and lipid metabolites
Liu, L., Han, D., Liu, H., Zhao, F., Lü, X., Wu, G., & Yi, Y. (2025) · Food Science and Human Wellness · doi:10.26599/fshw.2025.9250521
Anti-inflammatory effects and gut microbiota modulation of synbiotic mulberry in DSS-induced colitis rats
Ontawong, A., Thim-uam, A., Pengnet, S., Munkong, N., Wongputtisin, P., Kuntakhut, K., Riyamongkhol, P., Mann, D., & Amornlerdpison, D. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05309-9
Linking the Gut Microbiome to Metabolic Syndrome: Exploring Dietary Modifications and Fecal Microbiota Transplantation (FMT)
Baby, Dhiman, R., Tripathi, S., Kundu, S., & Priyadarshini, A. (2025) · Springer eBooks · doi:10.1007/978-981-96-6246-3_3
The Role of Probiotics in the Maintenance of Remission in Adult‐Onset Crohn’s Disease: A Systematic Review
Megapanou, M., Komninou, E., Zampeli, E., Gavriatopoulou, M., Ψαλτοπούλου, Θ., & Liontos, M. (2025) · Advanced Gut & Microbiome Research · doi:10.1155/agm3/7773978
Additional file 1 of ACE2 mediates tryptophan alleviation on diarrhea by repairing intestine barrier involved mTOR pathway
Li, J., Yan, Y., Fu, Y., Chen, Z., Yang, Y., Li, Y., Pan, J., Li, F., Zha, C., Miao, K., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26734116
Self-citation
Research Progress on the Association between Membranous Nephropathy and Intestinal Microbiota: From the Perspective of the Gut-Kidney Axis
聂小敏 (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.15123679
Exploring the Gut Ecosystem: Mechanism Studies From the Gut Microbiota to Inflammatory Cytokines to Inflammatory Bowel Disease
Tang, B., Cheng, W., Gu, A., Miao, Y., Yu, G., & Chen, J. (2026) · Immunology · doi:10.1111/imm.70114
The meta-analysis of randomized controlled trials on the effect of probiotics on immune factors in patients with inflammatory bowel disease (IBD)
Li, Y., Chen, Z., Huo, R., Huang, P., Zhang, C., Zhao, J., 田丰伟, Zhai, Q., & Zhang, C. (2026) · Food Nutrition · doi:10.1016/j.fnutr.2026.100056
Oral microbiota and gastroenterological diseases
Трухан, Д. И., Rozhkova, M. Y., Филиппович, С. А., & Trukhan, L. Y. (2026) · Medical alphabet · doi:10.33667/2078-5631-2026-5-7-15
Toward clinical translation: montmorillonite-enhanced Lactobacillus biofilm alleviates colitis by modulating the gut microbiota–bile acid axis
Wang, Z., Zhu, F., Zhang, J., Feng, K., Abudourexiti, W., Li, S., Guo, Y., Chen, M.-F., Yu, Z., Zhao, L., et al. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103211 · Cited by 1
Gut Microbiome in Chronic Disorder Management
Patnaik, S. K., Kandy, A. T., Mariappan, E., Negi, P., Nilewar, S. S., Bandaru, N., & Swaroop, A. K. (2026) · Springer eBooks · doi:10.1007/978-981-95-7494-0_15
Irritable bowel syndrome like symptoms in inflammatory bowel disease: Research progress
Zhou, S., Dong, H., Zhang, K., & Jiang, B. (2026) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v34.i4.325
A comparative evaluation of new prebiotic candidates. Part 2: In vitro assays using faecal inoculum from IBD patients
Martínez-Gómez, S., Sousa, J., Cordeiro, A., Barbosa, S. G., Franco‐Duarte, R., Pinheiro, A. C., Rodrigues, L. R., Silvério, S. C., Yáñez, R., & Alonso, J. L. (2026) · Food Research International · doi:10.1016/j.foodres.2026.119754
AI in Drug Discovery and Personalized Medicine Based on Pharmacomicrobiomics
Negi, S. S., Pandey, A., Dhiman, V. K., & Singh, D. (2026) · Advances in computational intelligence and robotics book series · doi:10.4018/979-8-3373-8172-5.ch003
The potency of native postbiotics and paraprobiotics in modulating inflammation by affecting the gut–kidney axis
Jouriani, F. H., Torfeh, M., Ashrafian, F., Rezaie, N., محمدی, م., Aghamohammad, S., & Rohani, M. (2026) · Animal Models and Experimental Medicine · doi:10.1002/ame2.70257
Indirubin attenuates DSS-induced colitis in mice and is associated with partial gut microbiota shifts and altered intestinal metabolic profiles
Shi, J., Cui, D., Yu, L., Zhang, D., & Gong, Y. (2026) · Food Research International · doi:10.1016/j.foodres.2026.120412
Bifidobacterium longum Subspecies infantis M63 Enhances the Colitis-Alleviating Effect of 2′-Fucosyllactose by Restoring Intestinal Barrier Function and Microbial Metabolism
Zhang, H., Li, X., Tan, M., Bao, Y., & Jiang, S. (2026) · Foods · doi:10.3390/foods15173113
Incorporation of prebiotics in medicine, supplement, and food product: health effectiveness, technological challenges, consumer perspectives, and future trends
Jafari, A., Karimzadeh‐Soureshjani, E., Kiani-Shamsabadi, D., Mohammadpour, H., & Mardani, H. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-29835-6.00004-6
Strain-specific evidence and life-stage considerations for Bifidobacterium longum in inflammatory bowel disease
Ma, J., Jin, J., Wang, X., He, Y., Zhang, L., Wang, J., Sun, Y., Du, P., Zhang, G., Liu, L., et al. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.110355
Self-citation

Authors: Zhang, X.-F., Guan, X.-X., Tang, Y.-J., Sun, J.-F., Wang, X.-K., Wang, W.-D., & Fan, J.-M.
Affiliations: Zhengzhou University (CN)
ORCID: Zhang, Xiao-Feng
Guan, Xiao-Xian
Tang, Yu-Jun
Sun, Jin-Feng
Wang, Xiao-Kai
Wang, Wei-Dong
Fan, Jian-Ming
Venue: European Journal of Nutrition
Publisher: Springer Science and Business Media LLC
Published: 2021-02-08
Volume: 60
Issue: 5
Pages: 2855-2875
ISSN: 1436-6207 (ISSN-L)
1436-6215
DOI: 10.1007/s00394-021-02503-5
OpenAlex: W3126487719
Cited by: 193
References: 84
Citations by year: 2026: 26 · 2025: 38 · 2024: 46 · 2023: 35 · 2022: 35 · 2021: 13
FWCI: 2.91
Type: journal article
Language: en
Update notices: correction (2021-05-24)
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: European Journal of Nutrition (publishedVersion)
PubMed (publishedVersion)
Funders: National Natural Science Foundation of China (31372453)
Science and Technology Department of Henan Province (152102310260)
Topics: Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords: inflammatory bowel disease, probiotics, prebiotics, synbiotics, gut microbiota, ulcerative colitis, remission, disease activity index, recurrence, Bifidobacterium
MeSH terms: Gastrointestinal Microbiome, Humans, Inflammatory Bowel Diseases, Probiotics, Prebiotics, Synbiotics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Clinical effects and gut microbiota changes of using probiotics, prebiotics or synbiotics in inflammatory bowel disease: a systematic review and meta-analysis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks